We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ITRK:LSEIntertek Group plc Analysis

Data as of 2026-06-17 - not real-time

£5,680.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Intertek Group plc is trading near its 52‑week high of 5,755 GBp with a current price of 5,680 GBp, well above the DCF‑derived fair value of roughly 2,540 GBp, suggesting the stock is significantly overvalued. Technical metrics show the price sitting above the 20‑day SMA (5,483 GBp) and the 50‑day SMA (5,031 GBp) but the MACD histogram is negative and the MACD line sits below its signal, indicating short‑term bearish momentum despite a bullish overall trend. The RSI of 67 points to an overbought condition, and the next resistance at 5,755 GBp looms close, limiting upside potential.
Fundamentally, the company delivers solid earnings with a 10% profit margin, a strong ROE of 28%, and a healthy dividend yield of 2.9% supported by a 74% payout ratio. Low beta (~0.5) and a 30‑day volatility of 34% reflect modest market sensitivity, while growing trading volume underpins liquidity. No material news items were identified that would materially shift the outlook, leaving the current valuation and operational performance as the primary drivers of the analysis.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram and overbought RSI
  • Price near resistance at 5,755 GBp
  • Significant overvaluation relative to DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Stable earnings and cash flow generation
  • Attractive dividend yield with sustainable payout
  • Moderate valuation gap that may narrow over time

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong ROE and consistent profitability
  • Diversified global client base reducing geographic concentration
  • Long‑term dividend growth potential despite current overvaluation

Key Metrics & Analysis

Financial Health

Revenue Growth2.00%
Profit Margin10.01%
P/E Ratio26.3
ROE28.24%
ROA9.94%
Debt/Equity146.18
P/B Ratio8.1
Op. Cash Flow£536.5M
Free Cash Flow£362.3M
Industry P/E31.2

Technical Analysis

TrendBullish
RSI67.3
Support£5,310.00
Resistance£5,755.00
MA 20£5,482.75
MA 50£5,030.70
MA 200£4,672.73
MACDBearish
VolumeIncreasing
Fear & Greed Index92.13

Valuation

Fair Value£2,538.00
Target Price£5,849.29
Upside/Downside2.98%
GradeOvervalued
TypeBlend
Dividend Yield2.91%

Risk Assessment

Beta0.49
Volatility34.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.